Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma

British Journal of Cancer

Volumn 57, Issue 1, 1988, Pages 121-126

  Christiansen, H ^a   Lampert, F ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CYTOLOGY; FEMALE; HUMAN; INFANT; KARYOTYPE; MALE; NEUROBLASTOMA; PROGNOSIS;

CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 1; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; HUMAN; INFANT; INFANT, NEWBORN; KARYOTYPING; MALE; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; PROTO-ONCOGENES; SUPPORT, NON-U.S. GOV'T;

EID: 0023835841     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1988.24     Document Type: Article

References (16)

1. BERTHOLD, F., BRANDEIS, W.E. & LAMPERT, F. (1986). Neuroblastoma: Diagnostic advances and therapeutic results in 370 patients. Monogr. Paediat., 18, 206 (Karger, Basel).
2. BRODEUR, G.M., GREEN, A.A., HAYES, F.A., WILLIAMS, K.J., WILLIAMS, D.L. & TSIATIS, A.A. (1981). Cytogenetic features of human neuroblastomas and cell lines. Cancer Res., 41, 4678.
3. BRODEUR, G.M., SEEGER, R.C., SCHWAB, M., VARMUS, H.E. & BISHOP, J.M. (1984). Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science, 224, 1121.
4. CHRISTIANSEN, H., FRANKE, F., BARTRAM, C.R. & 5 others (1987). Evolution of tumor cytogenetic aberrations and N-myc oncogene amplification in a case of disseminated neuroblastoma. Cancer Genet. Cytogenet., 26, 235.
5. EVANS, A.E., D'ANGIO, G.J., PROPERT, K., ANDERSON, J. & HANN, H.L. (1987). Prognostic factors in neuroblastoma. Cancer, 59, 1853.
6. FRANKE, F., FORSTER, W., RUDOLPH, B. & LAMPERT, F. (1985). Metastatic neuroblastoma in an infant: Translocation (1;11), deletion (2) and double minute chromosomes. Eur. J. Pediatr., 143, 305.
7. FRANKE, F., RUDOLPH, B., CHRISTIANSEN, H., HARBOTT, J. & LAMPERT, F. (1986a). Tumour karyotype may be important in the prognosis of human neuroblastoma. J. Cancer Res. Clin. Oncol., 111, 266.
8. FRANKE, F., RUDOLPH, B. & LAMPERT, F. (1986b). Translocation (19;?) in two stage II neuroblastomas. Cancer Genet. Cytogenet., 20, 129.
9. GANSLER, T., CHATTEN, J., VARELLO, M., BUNIN, G.R. & ATKINSON, B. (1986). Flow cytometric DNA analysis of neuroblastoma. Correlation with histology and clinical outcome. Cancer, 58, 2453.
10. GILBERT, F., FEDER, M., BALABAN, G. & 6 others (1984). Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res. 44, 5444.
11. HAYASHI, Y., HABU, Y., FUJII, Y., HANADA, R. & YAMAMOTO, K. (1986). Chromosome abnormalities in neuroblastomas found by VMA mass screening. Cancer Genet. Cytogenet, 22, 363.
12. KANEKO, Y., KANDA, N., MASEKI, N. & 5 others (1987). Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res., 47, 31 1.
13. LOOK, A.T., HAYES, F.A., NITSCHKE, R., MCWILLIAMS, N. & GREEN, A.A. (1984). Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N. Engl. J. Med., 311, 231.
14. ROSEN, N., REYNOLDS, C.P., THIELE, C.J., BIEDLER, J.L. & ISRAEL, M.A. (1986). Increased N-myc expression following progressive growth of human neuroblastoma. Cancer Res., 46, 4139.
15. SCHWAB, M., ALITALO, K., KLEMPNAUER, K.-H. & 6 others (1983). Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature, 305, 245.
16. SEEGER, R.C., BRODEUR, G.M., SATHER, H. & 4 others (1985). Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313, 111.